Robert Torray - Torray Fund Portfolio Performance Analysis (Q2 2026)
Investment performance metrics based on historical 13F filings data.
Data Coverage: June 2013 to June 2026 • Initial Portfolio Value: $0.00B
Performance calculated from first filing in our database. This may not represent the investor's entire career.
Portfolio Growth (Since First Filing)
+0.67B
+9,999%+
Winning Positions
+74.81%
193 wins / 258 positions
Average Gain (Winners)
$4.15M
+9,999%+ avg per position
Active Positions
88
40 losing positions
Portfolio Value Over Time
Total Positions Tracked
258
All holdings over time
Win/Loss Ratio
4.83
193 gains / 40 losses
Active vs. Exited
88 / 170
Current positions / Exited
Position Performance
Performance calculated from first appearance in 13F filings. Initial values represent position value when first tracked, not actual purchase prices.
| Symbol | Company | Sector | Entry | Status | Initial Value | Current Value | Gain/Loss | Return % |
|---|---|---|---|---|---|---|---|---|
| AVGO | Broadcom Inc. | Technology | Sep 2022 | ACTIVE | $1.04K | $38.33M | $38.33M | +9,999%+ |
| RPRX | Royalty Pharma | N/A | Dec 2021 | ACTIVE | $5.50K | $33.76M | $33.75M | +9,999%+ |
| CVX | Chevron Corporation | Energy | Jun 2013 | ACTIVE | $213.00 | $22.43M | $22.43M | +9,999%+ |
| BX | Blackstone Inc. | Financial Services | Jun 2019 | ACTIVE | $2.25K | $22.22M | $22.22M | +9,999%+ |
| CNA | CNA Financial Corporation | Financial Services | Sep 2024 | ACTIVE | $3.53M | $25.39M | $21.85M | +618.83% |
| AMGN | Amgen Inc. | Healthcare | Sep 2017 | ACTIVE | $1.05K | $21.64M | $21.64M | +9,999%+ |
| CEG | Constellation Energy Corporatio | Utilities | Dec 2024 | ACTIVE | $5.39M | $26.76M | $21.37M | +396.53% |
| CMCSA | Comcast Corporation | Communication Services | Sep 2020 | ACTIVE | $1.75K | $21.20M | $21.19M | +9,999%+ |
| ACN | Accenture plc | Technology | Jun 2013 | ACTIVE | $3.69K | $20.87M | $20.86M | +9,999%+ |
| ABBV | AbbVie Inc. | Healthcare | Jun 2016 | ACTIVE | $560.00 | $20.79M | $20.79M | +9,999%+ |
Important Note: Data Limitations
These metrics are based on 13F filing data which has significant limitations:
- Quarterly Snapshots Only: 13F filings show positions at quarter-end, not actual transaction prices
- No Transaction Prices: We cannot determine actual buy/sell prices, only end-of-quarter values
- Performance Estimates: Gains/losses are calculated from first appearance to last update using quarterly values
- Missing Data: Intra-quarter trades, dividends, corporate actions, and exact timing are not captured
- Educational Only: These metrics are estimates for understanding general investment patterns, not actual realized returns
Use these metrics for informational and educational purposes only. They represent broad trends, not precise investment performance.